Lenacapavir expands HIV prevention choices
Zimbabwe's Ministry of Health and Child Care has introduced lenacapavir, a twice-yearly injectable PrEP, to expand HIV prevention options. The rollout aims to provide individuals with more flexible, lifestyle-compatible choices for HIV protection.
Why it matters
Expanding access to long-acting injectable HIV prevention is a significant public health milestone in reducing infection rates in high-risk populations.
THE Health and Child Care ministry is stepping up efforts to widen HIV prevention options with the rollout of lenacapavir, a long-acting injectable PrEP administered twice a year.
The article reports on public health policy and medical access without political advocacy.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in